| Keynote Addresses |
 |
Kathryn (Kathi) L. Kellar, Ph.D. - Tuesday, March 4
Suspension Array Laboratory Director, Division of Scientific Resources
National Center for Preparedness, Detection and Control of Infectious Diseases
Centers for Disease Control
Presentation: Mindful of the Past with an Eye to the Future (pdf)
|
|
|
 |
Carlo Croce, M.D. - Wednesday, March 5
John W. Wolfe Chair in Human Cancer Genetics, Professor/Chair, Molecular Virology, Immunology and Medical Genetics, Director, Human Cancer Genetics Program at The Ohio State University, Comprehensive Cancer Center
Presentation: MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B (pdf)
|
|
|
| Life Science Research Speakers - Tuesday, March 4 |
 |
Christine Falk, Ph.D.
National Center for Tumor Diseases (NCT), German Research Center, DKFZ and the Institute for Immunology in Heidelberg, Immune Monitoring Unit
Group Leader
Presentation: The Multiplex Technology in Immunology: Cytokines, Phosphokinases and HLA/KIR Typing (pdf)
|
|
|
 |
Hai Tran, PharmD
The University of Texas MD Anderson Comprehensive Cancer Center
Assistant Professor, Clinical Pharmacology, Divisions of Cancer Medicine and Pharmacy, University of Texas M.D. Anderson Cancer Center
Presentation: Application of Multiplex Bead-based assays in Preclinical and Clinical Cancer Research (pdf)
|
|
|
 |
Luis Giavedoni, Ph.D.
Southwest Foundation for Biomedical Research
Scientist, Director SNPRC Flow Cytometry Core Facility, Interim Associate Director for Research
SNPRC Department of Virology and Immunology
Presentation: Use of the Luminex xMAP Technology for Validation of Nonhuman Primates as Best Animal Models for Human Diseases (pdf)
|
|
|
 |
Eric Miska, Ph.D.
University of Cambridge
Cancer Research UK Senior Fellow, Wellcome Trust/Cancer Research UK Gurdon Institute and Department of Biochemistry
Presentation: MicroRNA expression profiling of human breast cancer identifies new markers of tumour subtype (pdf)
|
|
|
 |
Kimberly Stegmaier, M.D.
Dana-Farber Cancer Institute and Children’s Hospital Boston
Assistant Professor of Pediatrics,
Broad Institute of Harvard University and Massachusetts Institute of Technology
Associate Member
Presentation: Signature-based Approaches to Small Molecule Library Screening (presentation not available)
|
|
|
 |
Troy E. Fuller, Ph.D.
Pfizer Animal Health
Senior Principal Scientist, VMRD Global Discovery
Presentation: Application of Multiplex Technology to Signature-Tagged Mutagenesis ofStreptococcus suis (pdf)
|
|
|
| Diagnostic Speakers - Wednesday, March 5 |
 |
Christine Robinson, Ph.D.
Denver Children's Hospital
Coordinator of Research, Development and Outcomes, Microbiology/Virology Laboratory
Presentation: The xTAG Respiratory Viral Panel (pdf)
|
|
|
 |
Kristen Keeling Reynolds, Ph.D.
PGxL Laboratories
Director of Laboratory Operations
Assistant Clinical Professor, Dept. Pathology and Laboratory Medicine, University of Louisville School of Medicine
Presentation: New Paradigms in Personalized Medicine: Predictive Models in Warfarin Pharmacogenetics (pdf)
|
|
|
 |
Gary Procop, M.D.
Department Chairman, Clinical Pathology
Cleveland Clinic Foundation
Presentation: The Detection and Differentiation of the Causes of Fungemia using Broad-Range PCR and Luminex xMAP® technology (pdf)
|
|
|
 |
Stephen Apfelroth, M.D., Ph.D., FCAP
Director of Clinical Laboratories
Albert Einstein School of Medicine - Jacobi Medical Center
Presentation: Implementation of Clinical Multiplex Testing in the Serology and Genetics Laboratories (pdf)
|
|
|
|
D. Brian Dawson, Ph.D., DABMG
Mayo Clinic, Rochester, MN
Chair, Division of Laboratory Genetics, Dept of Lab Medicine and Pathology
Presentation: Coupling FlexMAP Technology with MLPA for the Detection of Large Deletions and Duplications (pdf)
|
|
|
 |
Kamaljit Singh, M.D.
A/Director Clinical Microbiology, Attending, Infectious Disease
Rush University Medical Center
Presentation: A University Hospital Experience with RVP (pdf)
|
|
|
|
